Marie-Agnès Dragon-Durey

Overview

Best Publications

• Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults

  Véronique Fremeaux-Bacchi;Fadi Fakhouri;Arnaud Garnier;Frank Bienaimé

  839
  Citations

• Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

  Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  741
  Citations

• Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

  Aude Servais;Aude Servais;Laure-Hélène Noël;Lubka T. Roumenina;Moglie Le Quintrec

  636
  Citations

• Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome

  Marie-Agnès Dragon-Durey;Chantal Loirat;Sylvie Cloarec;Marie-Alice Macher

  592
  Citations

• Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations

  Fadi Fakhouri;Lubka Roumenina;François Provot;Marion Sallée

  576
  Citations

• Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic Syndrome

  Anne-Laure Sellier-Leclerc;Veronique Fremeaux-Bacchi;Marie-Agnès Dragon-Durey;Marie-Alice Macher

  543
  Citations

• Heterozygous and Homozygous Factor H Deficiencies Associated with Hemolytic Uremic Syndrome or Membranoproliferative Glomerulonephritis: Report and Genetic Analysis of 16 Cases

  Marie-Agnès Dragon-Durey;Véronique Frémeaux-Bacchi;Chantal Loirat;Jacques Blouin

  512
  Citations

• Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

  V Fremeaux-Bacchi;MA Dragon-Durey;J Blouin;C Vigneau

  470
  Citations

• Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome

  Marie-Agnès Dragon-Durey;Sidharth Kumar Sethi;Arvind Bagga;Caroline Blanc

  372
  Citations

• Inhibition of the mTORC pathway in the antiphospholipid syndrome.

  Guillaume Canaud;Frank Bienaimé;Fanny Tabarin;Guillaume Bataillon

  371
  Citations

• Atypical aHUS: State of the art.

  Carla M. Nester;Thomas Barbour;Santiago Rodriquez de Cordoba;Marie Agnes Dragon-Durey

  335
  Citations

• Genetic and Functional Analyses of Membrane Cofactor Protein (CD46) Mutations in Atypical Hemolytic Uremic Syndrome

  Véronique Fremeaux-Bacchi;Elizabeth A. Moulton;David Kavanagh;Marie-Agnès Dragon-Durey

  278
  Citations

• Y402H Complement factor H polymorphism associated with exudative age-related macular degeneration in the French population

  Souied Eh;Leveziel N;Richard F;Dragon-Durey Ma

  247
  Citations

• Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children

  Aditi Sinha;Ashima Gulati;Savita Saini;Caroline Blanc

  245
  Citations

• The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts

  Veronique Fremeaux-Bacchi;Elizabeth J Kemp;Judith A Goodship;Marie-Agnes Dragon-Durey

  238
  Citations

• Mutations in complement C3 predispose to development of atypical haemolytic uraemic syndrome

  V. Fremeaux-Bacchi;T. Goodship;C.H. Regnier;M.A. Dragon-Durey

  236
  Citations

• Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.

  Frank Bienaime;Frank Bienaime;Marie-Agnes Dragon-Durey;Catherine H. Regnier;Catherine H. Regnier;Sara C. Nilsson

  232
  Citations

• The high frequency of Complement Factor H-Related CFHR1 Gene Deletion is restricted to specific subgroups of patients with atypical Haemolytic Uraemic Syndrome

  Marie-Agnès Dragon-Durey;Caroline Blanc;Florence Marliot;Chantal Loirat

  206
  Citations

• Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome

  Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina;Mathieu Jablonski;Mathieu Jablonski;Mathieu Jablonski;Christophe Hue;Christophe Hue;Christophe Hue;Jacques Blouin

  194
  Citations

• Alternative complement pathway assessment in patients with atypical HUS.

  Lubka T. Roumenina;Chantal Loirat;Marie-Agnes Dragon-Durey;Lise Halbwachs-Mecarelli;Lise Halbwachs-Mecarelli

  184
  Citations

• A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.

  Lubka T. Roumenina;Lubka T. Roumenina;Lubka T. Roumenina;Marie Frimat;Marie Frimat;Elizabeth C. Miller;Francois Provot

  162
  Citations

• Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.

  P. Ghillani;C. André;C. Toly;A.M. Rouquette

  157
  Citations